HomeBGLC • NASDAQ
add
BioNexus Gene Lab Corp
Previous close
$3.21
Day range
$3.00 - $3.21
Year range
$2.01 - $8.40
Market cap
5.57M USD
Avg Volume
123.33K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.14M | -10.28% |
Operating expense | 930.43K | 76.00% |
Net income | -623.33K | -500.76% |
Net profit margin | -29.17 | -569.04% |
Earnings per share | — | — |
EBITDA | -560.30K | -290.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.60M | -38.35% |
Total assets | 9.48M | -15.07% |
Total liabilities | 1.71M | -6.00% |
Total equity | 7.77M | — |
Shares outstanding | 1.80M | — |
Price to book | 7.47 | — |
Return on assets | -14.74% | — |
Return on capital | -17.74% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -623.33K | -500.76% |
Cash from operations | -824.07K | -2,118.05% |
Cash from investing | -15.65K | -528.66% |
Cash from financing | -860.00 | -103.19% |
Net change in cash | -797.53K | -909.32% |
Free cash flow | -624.31K | -8,452.00% |
About
Founded
2017
Website
Employees
30
